In today’s video we will do some technical analysis of the stock charts of Valeant Pharmaceuticals (VRX). In the short term the technicals are to the upside with the catalyst being that Bill Ackman of Pershing Square Capital having sold his shares of Valeant.
Long Term the charts are very bearish and will be cut by another 50% in the coming year or two
Video Length – 00:07:49
Related Posts
Dollar Trades Heavier, Key Events Awaited
After Strong Early Market Performance, Tocagen Could Pop At Its Quiet Period Expiration
Morgan Stanley (MS) Beats Q1 Earnings And Revenue Estimates
Forex Forecast For EURUSD, GBPUSD, USDCAD, USDJPY – Monday, April 24
Blockchain project completes its biggest protocol change ever
What’s Your Gold Profile?
Leave A Comment